0001517026-21-000003.txt : 20210826 0001517026-21-000003.hdr.sgml : 20210826 20210826215510 ACCESSION NUMBER: 0001517026-21-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210825 FILED AS OF DATE: 20210826 DATE AS OF CHANGE: 20210826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verratti Mark CENTRAL INDEX KEY: 0001517026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 211213997 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SATL LAKE CITY STATE: UT ZIP: 84003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-25 0 0000899923 MYRIAD GENETICS INC MYGN 0001517026 Verratti Mark 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 President, Myriad Neuroscience Common Stock 2021-08-25 4 F 0 1082 34.81 D 156048 D Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021. By: Nathan A. Smith For: Mark Verratti 2021-08-26